Cost-Effectiveness of Lenvatinib in the Treatment of Patients With Unresectable Hepatocellular Carcinomas in Japan: An Analysis Using Data From Japanese Patients in the REFLECT Trial
Shunya Ikeda, Masatoshi Kudo, Namiki Izumi, Masahiro Kobayashi, Mie Azuma, Genevieve Meier, Janice Pan, Mika Ishii, Shuichi Kaneko
Topics & Concepts
LenvatinibHepatocellular carcinomaMedicineInternal medicineOncologySorafenibHepatocellular Carcinoma Treatment and PrognosisEconomic and Financial Impacts of CancerHealth Systems, Economic Evaluations, Quality of Life